Search

Author/Creator Anderson, Kristin G

1. Considerations for treatment duration in responders to immune checkpoint inhibitors. Issue 3 (2nd March 2021)

Authors:
Marron, Thomas U; Ryan, Aideen E; Reddy, Sangeetha M; Kaczanowska, Sabina; Younis, Rania H; Thakkar, Dipti; Zhang, Jiajia; Bartkowiak, Todd; Howard, Rachel; Anderson, Kristin G; Olson, Daniel; Naqash, Abdul Rafeh; Patel, Ravi B; Sachdev, Esha; Rodriguez-Ruiz, Maria E; Sheffer, Michal; Church, Sar...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 3(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy. Issue 3 (9th March 2022)

Authors:
Anderson, Kristin G; Oda, Shannon K; Bates, Breanna M; Burnett, Madison G; Rodgers Suarez, Magdalia; Ruskin, Susan L; Greenberg, Philip D
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 3(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Lymphocytic choriomeningitis virus persistence promotes effector-like memory differentiation and enhances mucosal T cell distribution. Issue 2 (13th November 2014)

Authors:
Beura, Lalit K; Anderson, Kristin G; Schenkel, Jason M; Locquiao, Jeremiah J; Fraser, Kathryn A; Vezys, Vaiva; Pepper, Marion; Masopust, David
Journal:
Journal of leukocyte biology
Issue:
Volume 97:Issue 2(2015)
Page Start:
217
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗